Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.16p
   
  • Change Today:
    -0.015p
  • 52 Week High: 0.42
  • 52 Week Low: 0.13
  • Currency: UK Pounds
  • Shares Issued: 1,320.30m
  • Volume: 30,216,630
  • Market Cap: £2.05m
  • RiskGrade: 435

Valirx Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -7630.8% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 64.5 n/a
Pr/Book 0.9  
Latest F'cast
Revenue -36.3% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Valirx Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (1.68) (2.34)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (2.60) (3.06)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.01 (2.30) (2.01)p n/a n/a n/a n/a 0.0%
31-Dec-24 0.05 (2.13) (1.45)p n/a n/a n/a n/a 0.0%
31-Dec-25 0.03 (2.42) (0.54)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Valirx Company Announcements

Update on Ambrose Healthcare shareholding 21-Oct-2026 07:00 RNS
Half-year Financial Report 15-Sep-2026 07:00 RNS
Cytolytix Patent Update 10-Aug-2026 07:00 RNS

Valirx ShareCast News

ValiRx launches prostate cancer subsidiary Blue ... 26-Aug-2025 ShareCast
Ambrose exercises ValiRx oncology option worth u... 20-Jun-2025 ShareCast
ValiRx terminates exclusive negotiations with Th... 03-Apr-2025 ShareCast

Valirx Top Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Latest Valirx Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.16p
Change Today -0.015p
% Change -8.82 %
52 Week High 0.42
52 Week Low 0.13
Volume 30,216,630
Shares Issued 1,320.30m
Market Cap £2.05m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.85% above the market average63.85% above the market average63.85% above the market average63.85% above the market average63.85% above the market average
2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average
Price Trend
95.01% below the market average95.01% below the market average95.01% below the market average95.01% below the market average95.01% below the market average
86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average
Income Not Available
Growth
0.93% above the market average0.93% above the market average0.93% above the market average0.93% above the market average0.93% above the market average
Sector averageSector averageSector averageSector averageSector average

Valirx Dividends

No dividends found

Trades for 11-Nov-2026

Time Volume / Share Price
12:30 119,570 @ 0.16p
11:17 7,522,773 @ 0.15p
11:28 3,826,880 @ 0.16p
11:18 3,717 @ 0.15p
11:18 9,282 @ 0.15p

Valirx Key Personnel

CFO Gerald Desler

Top of Page